IP Library Granted Patent US 8,911,983
Granted Patent B2
US 8,911,983 · App. 13/711,646 · Granted Dec 16, 2014

Pnp gene modification for improved xylose utilization in

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,911,983
App. No.
13/711,646
Granted
Dec 16, 2014
Kind
B2
Abstract

The endogenous pnp gene encoding polynucleotide phosphorylase in the Zymomonas genome was identified as a target for modification to provide improved xylose utilizing cells for ethanol production. The cells are in addition genetically modified to have increased expression of ribose-5-phosphate isomerase (RPI) activity, as compared to cells without this genetic modification, and are not limited in xylose isomerase activity in the absence of the pnp modification.

Claims (22)

1. A recombinant bacterial host cell comprising:

a) a xylose metabolic pathway comprising at least one polypeptide having xylose isomerase activity;

b) at least one genetic modification which increases ribose-5-phosphate isomerase activity in the host cell as compared with ribose-5-phosphate isomerase activity in the host cell lacking said genetic modification; and

c) at least one genetic modification in the sequence of an endogenous gene encoding polynucleotide phosphorylase that shortens the coding region resulting in expression of a C-terminal truncated protein;

wherein the bacterial host cell utilizes xylose to produce ethanol, and the xylose isomerase activity is not rate limiting in the bacterial host cell.

2. The recombinant host cell of claim 1 wherein the C-terminal truncated protein of (c) comprises at least 350 amino acids of the N-terminal amino acid sequence encoded by the endogenous gene encoding polynucleotide phosphorylase.

3. The recombinant host cell of claim 1 wherein the C-terminal truncated protein of (c) is part of a fusion protein comprising at least one non-native amino acid at the C-terminus.

4. The recombinant host cell of claim 1 wherein the at least one genetic modification which increases ribose-5-phosphate isomerase activity is over-expression of an endogenous gene encoding a polypeptide having ribose-5-phosphate isomerase activity.

5. The recombinant host cell of claim 1 wherein the at least one genetic modification which increases ribose-5-phosphate isomerase activity is expression of at least one non-endogenous gene encoding a polypeptide having ribose-5-phosphate isomerase activity.

6. The recombinant host cell of claim 1 wherein the polypeptide having ribose-5-phosphate isomerase activity has the EC classification EC 5.3.1.6.

7. The recombinant host cell of claim 6 wherein the polypeptide having ribose-5-phosphate isomerase activity is selected from the group consisting of ribose-5-phosphate isomerase A and ribose-5-phosphate isomerase B.

8. The recombinant host cell of claim 1 wherein the polypeptide having xylose isomerase activity provides xylose isomerase activity at greater than 0.25 micromoles product/mg protein/minute.

9. The recombinant host cell of claim 1 wherein the polypeptide having xylose isomerase activity has the EC classification EC 5.3.1.5.

10. The recombinant host cell of claim 1 wherein xylose isomerase activity is expressed using a method selected from the group consisting of from multiple genes, from a mutant highly active promoter, from a Group I xylose isomerase, and a combination thereof.

11. The recombinant host cell of claim 1 wherein at least one genetic modification is made which increases expression of ribulose-phosphate 3-epimerase as compared with ribulose-phosphate 3-epimerase activity in the host cell lacking said genetic modification.

12. The recombinant host cell of claim 11 wherein the polypeptide having ribulose-phosphate 3-epimerase activity has the EC classification EC 5.1.3.1.

13. The bacterial host cell of claim 1 wherein the cell is selected from the group consisting of Zymomonas and Zymobacter.

14. A process for producing ethanol comprising:

a) providing the recombinant bacterial host cell of claim 1 or 2 ; and

b) culturing the host cell of (a) in a medium comprising xylose whereby xylose is converted to ethanol.

15. The process of claim 14 wherein the polypeptide having ribose-5-phosphate isomerase activity of claim 1 (b) has the EC classification EC 5.3.1.6.

16. The process of claim 14 wherein the medium comprises either a mixture of sugars including xylose or xylose as a sole sugar.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 7, 2019
From: DUPONT US HOLDING, LLC
To: SUSTAINABLE TECHNOLOGY CORPORATION
Reel/Frame 050647/0412 →
CORRECTIVE ASSIGNMENT TO CORRECT THE DESIGNATION OF ASSIGNEE AS A DELAWARE CORPORATION TO A DELAWARE LIMITED LIABILITY COMPANY PREVIOUSLY RECORDED ON REEL 049880 FRAME 0001. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 28, 2019
From: E. I. DU PONT DE NEMOURS AND COMPANY
To: DUPONT US HOLDING, LLC
Reel/Frame 051502/0610 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2019
From: E. I. DU PONT DE NEMOURS AND COMPANY
To: DUPONT US HOLDING, LLC
Reel/Frame 049880/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 23, 2013
From: CAIMI, PERRY G.; QI, MIN; TAO, LUAN; VIITANEN, PAUL V.; YANG, JIANJUN
To: E. I. DU PONT DE NEMOURS AND COMPANY
Reel/Frame 029674/0837 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 16, 2013
From: CAIMI, PERRY G.; QI, MIN; TAO, LUAN; VIITANEN, PAUL V.; YANG, JIANJUN
To: E. I. DU PONT DE NEMOURS AND COMPANY
Reel/Frame 029639/0583 →